NDC codes

370405 NDC codes with hospital pricing data in the network.

• NDC 71449-0021-11 — Morphine sulfate 1 mg/mL preservative-free syringeAI (48 hospitals, 67–391 samples)
• NDC 70092-1518-07 — MORPHINE (PF) IN NS 1 MG/ML INTRAVENOUS SOLUTION [300126] (6 hospitals, 67–391 samples)
• NDC 70092-1129-05 — MORPHINE IN 0.9 % NACL 55 MG/55 ML INJECTION [300598] (6 hospitals, 67–391 samples)
• NDC 44567-0236-10 — Ceftazidime 2 gram IV injectionAI (703 hospitals, 138–390 samples)
• NDC 42494-0416-25 — Phenobarbital sodium injection, 130 mg per mLAI (441 hospitals, 39–390 samples)
• NDC 63323-0377-01 — Octreotide acetate injection 500 mcg/mLAI (894 hospitals, 39–390 samples)
• NDC 00409-4688-22 — Fluconazole 200 mg IV piggybackAI (192 hospitals, 39–390 samples)
• NDC 00536-1304-85 — Docusate sodium liquid stool softener, 473 mL bottleAI (127 hospitals, 273–390 samples)
• NDC 990798302 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTIONAI (76 hospitals, 201–390 samples)
• NDC 00169-3004-15 — Isophane human insulin pen, 100 units per mLAI (35 hospitals, 39–390 samples)
• NDC 00310-0950-36 — Goserelin 3.6 mg implantAI (89 hospitals, 219–390 samples)
• NDC 51672-2114-02 — Acetaminophen 80 mg rectal suppositoryAI (373 hospitals, 291–390 samples)
• NDC 00703-3321-04 — Octreotide acetate 500 mcg/mL injectionAI (112 hospitals, 39–390 samples)
• NDC 6079370001 — Penicillin G benzathine injection, 600,000 units per mLAI (27 hospitals, 39–390 samples)
• NDC 6079370010 — Penicillin G benzathine injection, 600,000 units per mLAI (56 hospitals, 39–390 samples)
• NDC 6079370102 — Penicillin G benzathine injection, 1,200,000 unitsAI (42 hospitals, 39–390 samples)
• NDC 6079370110 — Penicillin G benzathine injection, 1.2 million unitsAI (71 hospitals, 39–390 samples)
• NDC 6079370204 — Penicillin G benzathine injectionAI (48 hospitals, 39–390 samples)
• NDC 6079370210 — Penicillin G benzathine injection, 2.4 million unitsAI (46 hospitals, 39–390 samples)
• NDC 55150-0345-01 — Naloxone injection 2 mg/2 mL syringeAI (277 hospitals, 84–390 samples)
• NDC 60505-0796-04 — Enoxaparin 120 mg/0.8 mL prefilled syringeAI (154 hospitals, 39–390 samples)
• NDC 72205-0120-01 — LEVETIRACETAM 500 MG/5 ML INTRAVENOUS SOLUTIONAI (136 hospitals, 66–390 samples)
• NDC 99999-9023-37 — TECHNETIUM TC 99M TETROFOSMIN 1UD IV STUDY (9 hospitals, 75–390 samples)
• NDC 09999-1227-56 — FUROSEMIDE 2 MG/ML IN D5W IV NEONATAL (9 hospitals, 39–390 samples)
• NDC 00093-7581-56 — Aripiprazole 15 mg tabletAI (14 hospitals, 334–388 samples)
• NDC 55513-0880-01 — Romosozumab-aqqg injection, 105 mg prefilled syringeAI (283 hospitals, 253–388 samples)
• NDC 67850-0024-00 — Ampicillin 500 mg injectionAI (124 hospitals, 55–388 samples)
• NDC 00143-9534-10 — Linezolid 600 mg IV bagAI (173 hospitals, 136–388 samples)
• NDC 00169-2314-21 — NPH insulin pen, 100 units per mLAI (15 hospitals, 262–388 samples)
• NDC 10019-0075-87 — Esmolol in sodium chloride infusion bagAI (497 hospitals, 280–388 samples)
• NDC 66647-2140-00 — MORPHINE 1MG/ML 50ML PCA (2 hospitals, 289–388 samples)
• NDC 00781-3412-92 — Ampicillin 1 gram intravenous injectionAI (183 hospitals, 55–388 samples)
• NDC 70860-0114-15 — Ampicillin 1 gram injectionAI (126 hospitals, 55–388 samples)
• NDC 70860-0115-41 — Ampicillin 2 gram injectionAI (57 hospitals, 55–388 samples)
• NDC 70594-0084-02 — Ampicillin 250 mg injection solutionAI (78 hospitals, 55–388 samples)
• NDC 00781-9242-78 — Ampicillin sodium injection 250 mg powderAI (102 hospitals, 55–388 samples)
• NDC 70594-0084-01 — Ampicillin 250 mg injection solutionAI (62 hospitals, 55–388 samples)
• NDC 70594-0086-01 — Ampicillin 1 gram injectionAI (74 hospitals, 55–388 samples)
• NDC 70860-0113-15 — Ampicillin 500 mg injection solutionAI (73 hospitals, 55–388 samples)
• NDC 70594-0086-02 — Ampicillin 1 gram injectionAI (89 hospitals, 55–388 samples)
• NDC 66794-0220-02 — Ampicillin 250 mg injection solutionAI (49 hospitals, 55–388 samples)
• NDC 65219-0018-01 — Ampicillin 1 gram injection solutionAI (44 hospitals, 55–388 samples)
• NDC 70860-0114-41 — Ampicillin 1 gram injection solutionAI (49 hospitals, 55–388 samples)
• NDC 43598-0848-11 — Ziprasidone mesylate 20 mg injectionAI (442 hospitals, 72–387 samples)
• NDC 00143-9245-01 — Dacarbazine 200 mg intravenous injectionAI (307 hospitals, 252–387 samples)
• NDC 70842-0240-01 — Rezafungin 200 mg injection vialAI (310 hospitals, 324–387 samples)
• NDC 81284-0411-05 — Dihydroergotamine injection, 1 mg per mLAI (363 hospitals, 180–387 samples)
• NDC 70515-0261-10 — Digoxin injection, 0.5 mg per 2 mL vialAI (205 hospitals, 89–386 samples)
• NDC 63739-0588-10 — PREDNISONE 20 MG TABLETAI (169 hospitals, 125–386 samples)
• NDC 09220-0003-59 — MAGNESIUM SULFATE 20 GM/500ML IV SOLN (9 hospitals, 215–386 samples)